How important is JAK1 selectivity?

被引：0
|
作者：
Edwards, Christopher J. [1 ,2 ]
机构：
[1] Univ Hosp Southampton NHS Fdn Trust, Dept Rheumatol, Tremona Rd, Southampton SO16 6YD, Hants, England
[2] Univ Hosp Southampton NHS Fdn Trust, NIHR Clin Res Facil, Tremona Rd, Southampton SO16 6YD, Hants, England
来源：
RHEUMATOLOGY | 2021年 / 60卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：ii1 / ii2
页数：2
相关论文
共 50 条
  • [11] Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
    Ge, Huizhen
    Tang, Chunchao
    Pan, Yiting
    Yao, Xiaojun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [12] JAK1 Somatic Mutation in Myeloproliferative Neoplasm
    Arulogun, Suzanne O.
    Lai, Hock Choong
    Taylor, Debra
    Ambrosoli, Paula
    Magor, Graham
    Irving, Ian Michael
    Keng, Tee Beng
    Perkins, Andrew C.
    BLOOD, 2017, 130
  • [13] JAK1 somatic mutation in a myeloproliferative neoplasm
    Arulogun, Suzanne O.
    Choong, Hock-Lai
    Taylor, Debbie
    Ambrosoli, Paula
    Magor, Graham
    Irving, Ian M.
    Keng, Tee-Beng
    Perkins, Andrew C.
    HAEMATOLOGICA, 2017, 102 (08) : E324 - E327
  • [14] JAK1 inhibition and inflammatory bowel disease
    Harris, Clare
    Cummings, J. R. Fraser
    RHEUMATOLOGY, 2021, 60 : II45 - II51
  • [15] JAK1 inhibition and inflammatory bowel disease
    Harris, Clare
    Cummings, J. R. Fraser
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii45 - ii51
  • [16] JAK1 selective inhibitors for the treatment of spondyloarthropathies
    White, Jonathan P. E.
    Coates, Laura C.
    RHEUMATOLOGY, 2021, 60 : II39 - II44
  • [17] Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis
    Vaddi, Kris
    Sarlis, Nicholas J.
    Gupta, Vikas
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (16) : 2397 - 2407
  • [18] JAK1 selective inhibitors for the treatment of spondyloarthropathies
    White, Jonathan P. E.
    Coates, Laura C.
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii39 - ii44
  • [19] Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors
    Springuel, Lorraine
    Hornakova, Tekla
    Losdyck, Elisabeth
    Lambert, Fanny
    Leroy, Emilie
    Constantinescu, Stefan N.
    Flex, Elisabetta
    Tartaglia, Marco
    Knoops, Laurent
    Renauld, Jean-Christophe
    BLOOD, 2014, 124 (26) : 3924 - 3931
  • [20] JAK1/2 INHIBITION IN THE TREATMENT OF CGVHD
    Alchalby, H.
    Stuebig, T.
    Ayuk, F.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S539 - S540
12345